Litcius/Paper detail

Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience

Eleonora De Bellis, Silvia Imbergamo, Anna Candoni, Albana Liço, Ilaria Tanasi, Endri Mauro, Federico Mosna, Matteo Leoncin, Manuela Stulle, Davide Griguolo, Stefano Pravato, Livio Trentin, Davide Lazzarotto, Eros Di Bona, Renato Bassan, Elisa Lucchini, Monica Poiani, Clara Palmieri, Francesco Zaja

2022Leukemia Research27 citationsDOIOpen Access PDF

Topics & Concepts

MedicineVenetoclaxDecitabineInternal medicineAzacitidineMyeloid leukemiaHypomethylating agentHematologyNeutropeniaGastroenterologyLeukemiaOncologyChemotherapyChronic lymphocytic leukemiaGeneChemistryBiochemistryDNA methylationGene expressionAcute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentHematopoietic Stem Cell Transplantation
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience | Litcius